Suppr超能文献

消费者通过社区药剂师报告药品不良事件:三方利益相关者的看法

Consumers' adverse drug event reporting via community pharmacists: three stakeholder perception.

作者信息

Kitisopee Tanattha, Assanee Jirunya, Sorofman Bernard A, Watcharadmrongkun Suntaree

机构信息

Faculty of Pharmaceutical Sciences, Chulalongkorn University, 254 Phayathai Road, Pathumwan, Bangkok, 10330, Thailand.

College of Pharmacy, The University of Iowa, 115 South Grand Avenue, Iowa City, IA, 52242, USA.

出版信息

J Pharm Policy Pract. 2022 Mar 14;15(1):19. doi: 10.1186/s40545-022-00417-z.

Abstract

BACKGROUND

Adverse drug event (ADE) reporting is a significant process to increase consumer care and consumer safety associated with the use of medicines. An in-depth investigation into low ADE reporting by consumers and community pharmacists was undertaken to uncover interventions to improve reporting.

METHOD

In-depth interviewing of the three parties; consumers, pharmacists and employees of the Pharmacovigilance Center in Thailand, was used to collect the data. They were interviewed about ADE reporting experiences and contributing factors and problems of ADE reporting. Thematic analysis was used to interpret the results.

RESULT

The HPVC received few ADE reports from consumers. Most community pharmacists received ADE reports from consumers; however, the Pharmacovigilance Center received few ADE reports from community pharmacists. ADE reporting of community pharmacists and consumers were influenced by many factors which were categorized into four themes which were (1) "Cognition" (awareness, attitude and responsibility); (2) "Reporting process" (complication, competency, information deficiency, feedback, and resource); (3) "Inducer" (service orientation, acquaintanceship, motivation, severity level, regulatory and reward); and (4) "Obstacle" (doubt, belief and prosecution).

CONCLUSION

Health professionals should motivate consumers to report ADEs. Building social responsibility and benefits and increasing knowledge of reporting process, channels, and system to both community pharmacists and consumers were recommended. Providing rewards and making community pharmacists feel comfortable to report ADEs by simplifying the ADE form and providing training, guidelines, and an ADR assessment tool can drive them to report ADEs. Feedback to consumers by confirming whether it was ADE and feedback to pharmacists that the Pharmacovigilance Center received their reports and their reports were utilized were also important.

摘要

背景

药品不良事件(ADE)报告是提高与用药相关的消费者护理和消费者安全的重要过程。对消费者和社区药剂师低ADE报告率进行了深入调查,以发现改善报告的干预措施。

方法

通过对三方进行深入访谈来收集数据,这三方分别是消费者、药剂师以及泰国药物警戒中心的员工。就ADE报告经历、促成因素和ADE报告问题对他们进行了访谈。采用主题分析法来解读结果。

结果

HPVC收到的消费者ADE报告很少。大多数社区药剂师收到过消费者的ADE报告;然而,药物警戒中心收到的社区药剂师的ADE报告很少。社区药剂师和消费者的ADE报告受到多种因素影响,这些因素可分为四个主题:(1)“认知”(意识、态度和责任);(2)“报告流程”(复杂性、能力、信息不足、反馈和资源);(3)“诱因”(服务导向、相识度、动机、严重程度、监管和奖励);(4)“障碍”(怀疑、信念和起诉)。

结论

卫生专业人员应鼓励消费者报告ADE。建议培养社区药剂师和消费者的社会责任意识和利益意识,并增加他们对报告流程、渠道和系统的了解。通过简化ADE表格、提供培训、指南和药品不良反应评估工具来提供奖励并让社区药剂师放心报告ADE,可以促使他们报告ADE。向消费者确认是否为ADE并向药剂师反馈药物警戒中心已收到其报告且报告已被采用,这也很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f25/8919562/24f6ae9e84b6/40545_2022_417_Fig1_HTML.jpg

相似文献

1
Consumers' adverse drug event reporting via community pharmacists: three stakeholder perception.
J Pharm Policy Pract. 2022 Mar 14;15(1):19. doi: 10.1186/s40545-022-00417-z.
2
Analysis of a pharmacist-led adverse drug event management model for pharmacovigilance in an academic medical center hospital in China.
Ther Clin Risk Manag. 2018 Oct 30;14:2139-2147. doi: 10.2147/TCRM.S178297. eCollection 2018.
4
Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
Eur J Clin Pharmacol. 2015 Jul;71(7):883-90. doi: 10.1007/s00228-015-1867-2. Epub 2015 May 26.
5
Texas pharmacists' opinions on reporting serious adverse drug events to the Food and Drug Administration: a qualitative study.
Pharm World Sci. 2010 Oct;32(5):651-7. doi: 10.1007/s11096-010-9420-y. Epub 2010 Jul 23.
7
Examination of pharmacists' intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior.
Res Social Adm Pharm. 2011 Dec;7(4):369-82. doi: 10.1016/j.sapharm.2010.09.001. Epub 2010 Nov 5.
8
Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration.
Br J Clin Pharmacol. 2011 Jul;72(1):143-52. doi: 10.1111/j.1365-2125.2011.03944.x.
10
Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
Curr Med Res Opin. 2018 Jan;34(1):149-156. doi: 10.1080/03007995.2017.1361916. Epub 2017 Aug 30.

引用本文的文献

本文引用的文献

1
Adverse drug reaction reporting by community pharmacists-The barriers and facilitators.
Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1552-1559. doi: 10.1002/pds.4800. Epub 2019 May 27.
2
Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey.
Int J Clin Pharm. 2018 Aug;40(4):878-889. doi: 10.1007/s11096-018-0700-2. Epub 2018 Aug 10.
3
Factors affecting patient reporting of adverse drug reactions: a systematic review.
Br J Clin Pharmacol. 2017 Apr;83(4):875-883. doi: 10.1111/bcp.13159. Epub 2016 Nov 25.
4
Role of Pharmacovigilance in India: An overview.
Online J Public Health Inform. 2015 Jul 1;7(2):e223. doi: 10.5210/ojphi.v7i2.5595. eCollection 2015.
5
Patterns of Adverse Drug Reactions in Different Age Groups: Analysis of Spontaneous Reports by Community Pharmacists.
PLoS One. 2015 Jul 14;10(7):e0132916. doi: 10.1371/journal.pone.0132916. eCollection 2015.
6
Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
Eur J Clin Pharmacol. 2015 Jul;71(7):883-90. doi: 10.1007/s00228-015-1867-2. Epub 2015 May 26.
7
Community pharmacists' knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia.
Saudi Pharm J. 2014 Nov;22(5):411-8. doi: 10.1016/j.jsps.2013.07.005. Epub 2013 Aug 21.
9
Adverse drug reactions reporting : Knowledge and opinion of general public in Penang, Malaysia.
J Pharm Bioallied Sci. 2013 Jul;5(3):224-8. doi: 10.4103/0975-7406.116824.
10
Patients' motives for participating in active post-marketing surveillance.
Pharmacoepidemiol Drug Saf. 2013 Jan;22(1):70-6. doi: 10.1002/pds.3327. Epub 2012 Jul 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验